Clinical trial

Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study

NCT04409795

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-08-26

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2021-08-26Date precision: day

Registry last updated2025-02-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

Monogenic Diabetesunresolved

Interventions

Metformin Extended Release Oral TabletDRUG · verified · RxNorm: metformin Extended Release Oral Tablet

SitagliptinDRUG · verified · RxNorm: sitagliptin

Sponsors & collaborators

Joslin Diabetes Centerlead sponsor

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04409795 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.